Fox John, Thomson Richard
Cancer Research UK, London WC2A 3PX, UK.
Proc AMIA Symp. 2002:265-9.
Developers of Clinical Decision Support Systems (CDSSs) have to date been more concerned with the efficacy of systems (e.g. measurable improvements in clinical outcomes) than with safety (e.g. potential for harmful side-effects). In future CDSS developers will be required (by the courts etc.) to acknowledge a "duty of care" covering all aspects of design, development and deployment. Experience in the transport, power and other safety-critical industries has led to a range of quality and safety assurance methods whose adoption may be needed before CDSSs can safely become an integral part of routine patient care, and before the trust of healthcare professionals, patients and other stakeholders can be gained. No single method will be sufficient for safe development and deployment; a range of techniques will be needed and used selectively. This paper is a contribution to discussion of quality, safety and legal liability issues in the medical informatics community.
临床决策支持系统(CDSS)的开发者至今更关注系统的功效(如临床结果的可衡量改善)而非安全性(如有害副作用的可能性)。未来,CDSS开发者将被(法院等)要求承认涵盖设计、开发和部署所有方面的“注意义务”。运输、电力和其他对安全要求极高的行业的经验催生了一系列质量和安全保证方法,在CDSS能够安全地成为常规患者护理的一个组成部分之前,以及在获得医疗专业人员、患者和其他利益相关者的信任之前,可能需要采用这些方法。没有单一的方法足以实现安全的开发和部署;将需要并选择性地使用一系列技术。本文有助于医学信息学界对质量、安全和法律责任问题的讨论。